,NSG 533 Advanced Pharmacology Exam 1
Study Guide Wilkes University High-Yield
Pharmacology 150 Q&A + Rationales
2026/2027
1. A 68-year-old patient with heart failure and atrial fibrillation is being started on digoxin. The
nurse practitioner considers the patient's renal function because digoxin is primarily eliminated
renally. Which pharmacokinetic parameter is most directly affected by reduced renal clearance,
thereby increasing the risk of digoxin toxicity?
A. Volume of distribution
B. Hepatic metabolism
C. Elimination half-life
D. Protein binding
Correct Answer: C. Elimination half-life
Rationale: Digoxin is excreted predominantly unchanged by the kidneys. Reduced renal
clearance prolongs the elimination half-life, causing drug accumulation and increased risk of
toxicity. Volume of distribution, hepatic metabolism, and protein binding are not primarily
altered by renal impairment. Thus, C is correct.
2. Which pharmacokinetic process is primarily affected by a patient's serum albumin levels?
A. Metabolism
,B. Absorption
C. Distribution
D. Excretion
Correct Answer: C. Distribution
Rationale: Distribution involves the transport of a drug by the bloodstream to its site of action.
Many drugs bind to plasma proteins like albumin, and only the unbound portion is
pharmacologically active. If albumin levels are low, as seen in malnutrition or liver disease, the
concentration of free drug increases, potentially leading to toxicity.
3. When a drug is an inducer of the Cytochrome P450 (CYP) enzyme system, what is the most
likely clinical outcome for a co-administered substrate?
A. Prolonged half-life of the substrate drug
B. Increased plasma levels of the substrate drug
C. Decreased plasma levels of the substrate drug
D. Decreased rate of metabolism for the substrate drug
Correct Answer: C. Decreased plasma levels of the substrate drug
Rationale: Enzyme induction involves the stimulation of CYP enzymes, which increases the
metabolic capacity of the liver. This results in faster breakdown of substrate drugs, leading to
lower plasma concentrations and potentially subtherapeutic effects. Clinicians must often
increase the dose of the substrate drug when an inducer is present.
, 4. A drug with a high therapeutic index (TI) is generally considered:
A. Potentially toxic at standard doses
B. Relatively safe
C. Likely to cause significant side effects
D. Highly potent
Correct Answer: B. Relatively safe
Rationale: The therapeutic index is a ratio that compares the blood concentration at which a
drug becomes toxic to the concentration at which it is effective. A high therapeutic index
indicates a wide margin of safety between the therapeutic and lethal doses. Drugs like penicillin
have high TIs, whereas drugs like digoxin have low TIs and require careful monitoring.
5. Which of the following describes a drug that binds to a receptor and produces a maximal
biological response?
A. Full Agonist
B. Antagonist
C. Partial Agonist
D. Inverse Agonist
Correct Answer: A. Full Agonist
Study Guide Wilkes University High-Yield
Pharmacology 150 Q&A + Rationales
2026/2027
1. A 68-year-old patient with heart failure and atrial fibrillation is being started on digoxin. The
nurse practitioner considers the patient's renal function because digoxin is primarily eliminated
renally. Which pharmacokinetic parameter is most directly affected by reduced renal clearance,
thereby increasing the risk of digoxin toxicity?
A. Volume of distribution
B. Hepatic metabolism
C. Elimination half-life
D. Protein binding
Correct Answer: C. Elimination half-life
Rationale: Digoxin is excreted predominantly unchanged by the kidneys. Reduced renal
clearance prolongs the elimination half-life, causing drug accumulation and increased risk of
toxicity. Volume of distribution, hepatic metabolism, and protein binding are not primarily
altered by renal impairment. Thus, C is correct.
2. Which pharmacokinetic process is primarily affected by a patient's serum albumin levels?
A. Metabolism
,B. Absorption
C. Distribution
D. Excretion
Correct Answer: C. Distribution
Rationale: Distribution involves the transport of a drug by the bloodstream to its site of action.
Many drugs bind to plasma proteins like albumin, and only the unbound portion is
pharmacologically active. If albumin levels are low, as seen in malnutrition or liver disease, the
concentration of free drug increases, potentially leading to toxicity.
3. When a drug is an inducer of the Cytochrome P450 (CYP) enzyme system, what is the most
likely clinical outcome for a co-administered substrate?
A. Prolonged half-life of the substrate drug
B. Increased plasma levels of the substrate drug
C. Decreased plasma levels of the substrate drug
D. Decreased rate of metabolism for the substrate drug
Correct Answer: C. Decreased plasma levels of the substrate drug
Rationale: Enzyme induction involves the stimulation of CYP enzymes, which increases the
metabolic capacity of the liver. This results in faster breakdown of substrate drugs, leading to
lower plasma concentrations and potentially subtherapeutic effects. Clinicians must often
increase the dose of the substrate drug when an inducer is present.
, 4. A drug with a high therapeutic index (TI) is generally considered:
A. Potentially toxic at standard doses
B. Relatively safe
C. Likely to cause significant side effects
D. Highly potent
Correct Answer: B. Relatively safe
Rationale: The therapeutic index is a ratio that compares the blood concentration at which a
drug becomes toxic to the concentration at which it is effective. A high therapeutic index
indicates a wide margin of safety between the therapeutic and lethal doses. Drugs like penicillin
have high TIs, whereas drugs like digoxin have low TIs and require careful monitoring.
5. Which of the following describes a drug that binds to a receptor and produces a maximal
biological response?
A. Full Agonist
B. Antagonist
C. Partial Agonist
D. Inverse Agonist
Correct Answer: A. Full Agonist
